News Agency
Men's Weekly

Hepagene Therapeutics to Present at the European Association for the Study of the Liver (EASL) Congress 2023

  • Written by PR Newswire

SHANGHAI, May 25, 2023 /PRNewswire/ -- Hepagene Therapeutics, Inc., a clinical stage biopharmaceutical company focusing on developing novel therapies for patients with chronic liver diseases, today announced that Hepagene will present two posters highlighting the preclinical and clinical development for its two non-alcoholic steatohepatitis (NASH)...

Read more: Hepagene Therapeutics to Present at the European Association for the Study of the Liver (EASL)...

How Downsizing to a Caravan Can Transform Your Lifestyle

If you’re curious about simplifying life while keeping the sense of adventure, caravan and camping sales offer an inviting gateway. Downsizing to a caravan can transform your daily routine from wrangling a cluttered house every morning to a more manageable... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion